POLYDRUG ABUSE AS A PATHOPLASTIC FACTOR INFLUENCING THE MANIFESTATIONS OF SCHIZOPHRENIA SPECTRUM DISORDERS

Abstract

The comparison of clinical-dynamic characteristics and social functioning indicators of 76 patients with schizophrenia and alcohol addiction and 46 patients with schizophrenia and polydrug addiction was carried out. The correlation between type of addiction, clinical-dynamic characteristics and indicators of social functioning were identified. Addiction to alcohol is associated with low intensity of psychopathological symptoms and higher rate of social functioning while polydrug addiction is associated with more severe schizophrenia course and low indicators of social adaptation.

Keywords

comorbidity / schizophrenia / schizophrenia spectrum disorders / alcohol addiction / polydrug addiction / dual diagnosis

References

[1] Барденштейн Л.М., Пивень Б.Н. Коморбидные формы психических заболеваний. М.: РИФ Стройматериалы, 2008. 120 с.

[2] Гофман А.Г. О некоторых особенностях синдрома вербального галлюциноза при разных формах шизофрении, осложненной хроническим алкоголизмом / Вопросы социальной и клинической психоневрологии. М., 1965. С. 130-139.

[3] Гофман А.Г., Яшкина И.В., Пономарева Н.А. Опыт изучения эндогенных психических заболеваний, сочетающихся с опийной наркоманией // Социальная и клиническая психиатрия. 1999. № 3. С. 79-80.

[4] Добровольская А.Е., Зиновьев С.В. Пути первичного выявления психически больных с сопутствующей аддиктивной патологией // Вестник неврологии, психиатрии и нейрохирургии. 2011. №9. С. 68-72.

[5] Добровольская А.Е., Софронов А.Г., Пашковский В.Э. Некоторые социально-демографические и клинико-динамические показатели больных шизофренией, отягощённой злоупотреблением психоактивными веществами // Наркология. 2012. Т.122. №2. С. 50-53.

[6] Клименко Т.В Патологическое влечение к наркотическим средствам в структуре сочетанной психической патологии : дисс. … докт. мед. наук. М., 1996. 354 с.

[7] Красильников Г.Т., Дресвянников В.Л., Бохан Н.А. Коморбидные аддиктивные расстройства у больных шизофренией // Наркология. 2002. № 6. С. 24-31.

[8] Софронов А.Г. Клинико-экспериментальное обоснование новых подходов к оказанию психиатрической и токсикологической помощи при злоупотреблении опиатами: дисс. … докт. мед. наук. СПб, 1995. 374 с.

[9] Чирко В.В., Дёмина М.В. Очерки клинической наркологии (наркомании и токсикомании: клиника, течение, терапия). М.: Медпрактика, 2002. 240 с.

[10] Allebeck P., Adamsson C., Engstrom et.al.Cannabis and schizophrenia: A longitudinal study of cases treated in Stockholm // Acta Psychiatr. Scand. 1993. Vol. 88. P. 21-24.

[11] Angst J., Sellaro R., Merikangas K.R. Multimorbidity of psychiatric disorders as an indicator of clinical severity // Eur. Arch. Psychiatry. 2002. Vol. 252. P. 147-54.

[12] Bersani G., Orlandi V., Kotzalidis G.D., Pancheri P. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes // Eur. Arch. Psych. Clin. Neurosci. 2002. Vol. 252, №2. P. 86-92.

[13] Binswanger K. Uber schizoide Alkoholiker // Z. Ges. Neurol. Psychiat. 1920. Vol. 60. P. 127-159.

[14] Bühler B., Hambrecht M., Löffler W., an der Heiden W., Häfner H. Precipitation and determination of the onset and course of schizophrenia by substance abuse - a retrospective and prospective study of 232 population-based first illness episodes // Schizophr. Res. 2002. Vol. 54. №3. P. 243-51.

[15] Cantwell R. Scottish Comorbidity Study Group Substance use and schizophrenia: effects on symptoms, social functioning and service use // Br. J. Psychiatry. 2003. Vol. 182. P. 324-329.

[16] Caspari D. Cannabis and schizophrenia: results of a follow-up study // Eur. Arch. Psychiatry Clin. Neurosci. 1999. Vol. 249, №1. P. 45-9.

[17] Cloninger C.R., M. Maj, W. Gaebel, J.J. López-Ibor, et al. Implications of comorbidity for the classification of mental disorders: the need for a psychobiology of coherence. In: Psychiatric Diagnosis and Classification. Chichester: John Wiley & Sons,2002. P. 79-105.

[18] Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcome // Schizophr. Res. 1999. Vol. 35. P. 93-100.

[19] Kendler K.S. Major depression and generalised anxiety disorder : same genes, (partly) different environments - Revisited // Br. J. Psychiatry. 1996. Vol. 168. P. 68-75.

[20] Kendler K.S., Prescott C.A., Myers J. et al. The structure of genetic and environmental risk factors for common psychiatric and substance abuse disorders in men and women // Arch. Gen. Psychiatry. 2003. Vol. 60. P. 929-937.

[21] Kraepelin E. Die Erscheinungsformen des Irreseins // Zeitschrift für die gesamte Neurologie und Psychiatrie. 1920. Vol. 62. P. 1-29.

[22] Krueger R.F., Hicks B.M., Patrick C.J. et al. Etiologic connections among substance dependence, antisocial behavior, and personality : modeling the externalizing spectrum // J. Abnorm. Psychol. 2002. Vol. 111. P. 411-424.

[23] Maj M. ‘Psychiatric comorbidity’ : an artefact of current diagnostic systems? // Br. J. Psychiatry. 2005. Vol. 186. P. 182-184.

[24] Middeldorp C.M., Cath D.C., Van Dyck R. et al. The comorbidity of anxiety and depression in the perspective of genetic epidemiology : a review of twin and family studies // Psychological Medicine. 2005. Vol. 35, №5. P. 611-624.

[25] Peralta V., Cuesta M.J. Influence of cannabis abuse on schizophrenic psychopathology // Acta Psychiatr. Scand. 1992. Vol. 85, №2. P. 127-130.

[26] Ross S., Peselow E. Co-Occurring Psychotic and Addictive Disorders : Neurobiology and Diagnosis // Clin. Neuropharm. 2012. Vol. 35. P. 235-243.

[27] Soyka M., Albus M., Immler B., Kathmann N., Hippius H. Psychopathology in dual diagnosis and non-addicted schizophrenics - are there differences? // Eur. Arch. Psychiatry Clin. Neurosci. 2001. Vol. 251, №5. P. 232-238.

[28] Uchtenhagen A. Schizophrenia and substance dependence // Schweiz. Arch. Neurol. Psychiatr. 1995. Vol. 146, № 5. P. 215-223.

[29] Vaidyanathan U., Patrick C.J., Iacono W.G. Patterns of comorbidity among mental disorders: a person-centered approach // Compr. Psychiatry. 2011. Vol. 52, №5. P. 527-535.

[30] Westermeyer J. Comorbid Schizophrenia and Substance Abuse : A Review of Epidemiology and Course // Am. J. Addict. 2006. Vol. 15, №5. P. 345-355.

[31] Zisook S., Heaton R., Moranville J. et al. Past substance abuse and clinical course of schizophrenia // Am. J. Psychiatry. 1992. Vol. 149. P. 552-553.

RIGHTS & PERMISSIONS

Sofronov A.G., Dobrovolskaya A.E., Pashkovski V.E.